These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4570619)

  • 41. Virulence factors and resistance mechanisms of Serratia marcescens. A short review.
    Rodrigues AP; Holanda AR; Lustosa GP; Nóbrega SM; Santana WJ; Souza LB; Coutinho HD
    Acta Microbiol Immunol Hung; 2006 Mar; 53(1):89-93. PubMed ID: 16696552
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Search for Serratia.
    Black WA; Hodgson R
    J Clin Pathol; 1971 Jul; 24(5):444-8. PubMed ID: 4937136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serratia marcescens outbreak in a neonatal intensive care unit: crucial role of implementing hand hygiene among external consultants.
    Montagnani C; Cocchi P; Lega L; Campana S; Biermann KP; Braggion C; Pecile P; Chiappini E; de Martino M; Galli L
    BMC Infect Dis; 2015 Jan; 15():11. PubMed ID: 25582674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An optimal zone of colistin activity with Serratia marcescens.
    Annear DI
    Med J Aust; 1970 Aug; 2(5):225-7. PubMed ID: 4917131
    [No Abstract]   [Full Text] [Related]  

  • 45. Identification of a red-pigmented bacterium producing a potent anti-tumor N-alkylated prodigiosin as Serratia marcescens.
    Deorukhkar AA; Chander R; Ghosh SB; Sainis KB
    Res Microbiol; 2007 Jun; 158(5):399-404. PubMed ID: 17467243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and characterization of nanoparticles conjugated tannase and using it for enhancement of antibacterial activity of tannase produced by Serratia marcescens.
    Nsayef Muslim DS; Abbas Dham Z; J Mohammed DN
    Microb Pathog; 2017 Sep; 110():484-493. PubMed ID: 28735079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of response surface methodology in medium optimization for protease production by the new strain of Serratia marcescens SB08.
    Venil CK; Lakshmanaperumalsamy P
    Pol J Microbiol; 2009; 58(2):117-24. PubMed ID: 19824395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An epizootic of Serratia marcescens (Enterobacteriaceae) in Periplaneta fuliginosa (Blattaria) and a suggested method for control.
    Rueger ME; Olson TA
    J Med Entomol; 1969 May; 6(2):190. PubMed ID: 4897002
    [No Abstract]   [Full Text] [Related]  

  • 49. Pigment formation in L-forms of Serratia marcescens.
    Hubert EG; Potter CS; Kalmanson GM; Guze LB
    J Gen Microbiol; 1969 Feb; 55(2):165-7. PubMed ID: 4885040
    [No Abstract]   [Full Text] [Related]  

  • 50. CTX-M and TEM as predominant types of extended spectrum beta-lactamases among Serratia marcescens isolated from solid organ recipients.
    Mlynarczyk A; Szymanek K; Sawicka-Grzelak A; Pazik J; Buczkowska T; Durlik M; Lagiewska B; Pacholczyk M; Chmura A; Paczek L; Mlynarczyk G
    Transplant Proc; 2009 Oct; 41(8):3253-5. PubMed ID: 19857723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the Phoenix 100 ID/AST system and NID panel for identification of Enterobacteriaceae, Vibrionaceae, and commonly isolated nonenteric gram-negative bacilli.
    O'Hara CM
    J Clin Microbiol; 2006 Mar; 44(3):928-33. PubMed ID: 16517878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nosocomial infections due to Serratia marcescens.
    Deodhar LP; Tendolkar UM
    J Postgrad Med; 1984 Apr; 30(2):89-90. PubMed ID: 6396403
    [No Abstract]   [Full Text] [Related]  

  • 53. Evasion of cellular ocular defenses by contact lens isolates of Serratia marcescens.
    Hume EB; Stapleton F; Willcox MD
    Eye Contact Lens; 2003 Apr; 29(2):108-12. PubMed ID: 12695715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolation and composition of oligosaccharide cores from endotoxins of two Serratia marcescens strains.
    Wang CS; Burngs RK; Alaupovic P
    J Bacteriol; 1974 Nov; 120(2):990-3. PubMed ID: 4616956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Infection with Serratia marcescens in newborn infants. Clinical aspects, therapy and disease course].
    Scharf JW; Wild F; Guggenbichler JP
    Monatsschr Kinderheilkd; 1991 Oct; 139(10):695-8. PubMed ID: 1961210
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of Pseudomonas aeruginosa and Serratia marcescens with extended-wear soft contact lenses in asymptomatic patients.
    Ahanotu EN; Ahearn DG
    CLAO J; 2002 Jul; 28(3):157-9. PubMed ID: 12144237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outbreaks of Serratia marcescens bacteriuria in a neurosurgical intensive care unit of a tertiary care teaching hospital: a clinical, epidemiologic, and laboratory perspective.
    Yoon HJ; Choi JY; Park YS; Kim CO; Kim JM; Yong DE; Lee KW; Song YG
    Am J Infect Control; 2005 Dec; 33(10):595-601. PubMed ID: 16330308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biochemical characteristics and antibiotic susceptibilities of Serratia marcescens isolated from clinical specimens.
    Chong Y; Yi KN; Lee SY
    Yonsei Med J; 1978; 19(1):32-8. PubMed ID: 382648
    [No Abstract]   [Full Text] [Related]  

  • 59. Serratia species isolated from bovine intramammary infections.
    Todhunter DA; Smith KL; Hogan JS
    J Dairy Sci; 1991 Jun; 74(6):1860-5. PubMed ID: 1894795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Serratia marcescens in bovine mastitis. Bibliography and a case study (author's transl)].
    Lium ER
    Nord Vet Med; 1977 Dec; 29(12):529-32. PubMed ID: 341073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.